Form Type: 4

SEC EDGAR Link
Accession Number:0001237899-14-000069
Date:2014-10-24
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
Original Submission Date:

Reporting Person:

BROWN MICHAEL S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2014-10-24 M 5,000 a $57.11 5,000 direct
COMMON STOCK 2014-10-24 S 5,000 d $399.00 0 direct
COMMON STOCK 2014-10-24 0 $0.00 20,349 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 57.11 2014-10-24 deemed execution date M 5,000 (d) 2022-01-03 common stock 5,000 $57.11 9,000 direct
Footnotes
IDfootnote
f1 disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c).
f2 the stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
WhaleWisdom Logo

Elevate your investments